Country: Stati Uniti
Lingwa: Ingliż
Sors: NLM (National Library of Medicine)
POTASSIUM CITRATE (UNII: EE90ONI6FF) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL), CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL)
Westminster Pharmaceuticals, LLC
ORAL
PRESCRIPTION DRUG
Potassium Citrate and Citric Acid Oral Solution USP is an effective alkalinizing agent useful in those conditions where long-term maintenance of an alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract, especially when the administration of sodium salts is undesirable or contraindicated. In addition, it is a valuable adjuvant when administered with uricosuric agents in gout therapy, since urates tend to crystallize out of an acid urine. It is also effective in correcting the acidosis of certain renal tubular disorders where the administration of potassium citrate may be preferable. This product is highly concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. This product alkalinizes the urine without producing a systemic alkalosis in recommended dosage. It is highly palatable, pleasant tasting and tolerable, even when administered for l
Potassium Citrate and Citric Acid Oral Solution USP is a (red colored; cherry flavored) oral solution and is supplied in the following oral dosage form: NDC 69367-321-16 (16 fl oz bottles). Keep tightly closed. Store at controlled room temperature, 20°-25°C (68°-77°F). Protect from excessive heat and freezing. Tamper evident by foil seal under cap. Do not use if foil seal is broken or missing. Dispense in a tight, light-resistant container as defined in the USP/NF with a childresistant closure. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSAGE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY. Call your doctor for medical advice about side effects. You may report side effects to Westminster Pharmaceuticals, LLC at 1-844-221-7294.
unapproved drug other
POTASSIUM CITRATE AND CITRIC ACID- POTASSIUM CITRATE AND CITRIC ACID MONOHYDRATE SOLUTION WESTMINSTER PHARMACEUTICALS, LLC _Disclaimer: This drug has not been found by FDA to be safe and effective, and this_ _labeling has not been approved by FDA. For further information about unapproved_ _drugs, click here._ ---------- POTASSIUM CITRATE AND CITRIC ACID ORAL SOLUTION USP RX ONLY NDC 69367-321-16 DESCRIPTION Potassium Citrate and Citric Acid Oral Solution USP is a stable and pleasant-tasting oral systemic alkalizer containing potassium citrate and citric acid in a sugar-free, non alcoholic base. Potassium Citrate and Citric Acid Oral Solution USP contains in each teaspoonful (5 mL): Potassium Citrate Monohydrate 1100 mg Citric Acid Monohydrate 334 mg Each mL contains 2 mEq potassium ion and is equivalent to 2 mEq bicarbonate (HCO ). INACTIVE INGREDIENTS cherry flavor, FD&C red #40, purified water, sodium benzoate, sodium saccharin, sorbitol solution. ACTIONS Potassium citrate is absorbed and metabolized to potassium bicarbonate, thus acting as a systemic alkalizer. The effects are essentially those of chlorides before absorption and those of bicarbonates subsequently. Oxidation is virtually complete so that less than 5% of the potassium citrate is excreted in the urine unchanged. INDICATIONS AND USAGE Potassium Citrate and Citric Acid Oral Solution USP is an effective alkalinizing agent useful in those conditions where long-term maintenance of an alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract, especially when the administration of sodium salts is undesirable or contraindicated. In addition, it is a valuable adjuvant when administered with uricosuric agents in gout therapy, since urates tend to crystallize out of an acid urine. It is also effective in correcting the acidosis of certain renal tubular disorders where the administration of potassium citrate may be 3 certain renal tubular disorders where the administration of potassium citrate may be preferable. Aqra d-dokument sħiħ